brusatol has been researched along with Experimental Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, IH; Ibuka, T; Imakura, Y; Lee, KH; Liou, YF; Okano, M; Sims, D | 1 |
| Eigebaly, SA; Hall, IH; Imakura, Y; Lee, KH; Sumida, Y; Wu, RY | 1 |
2 other study(ies) available for brusatol and Experimental Leukemia
| Article | Year |
|---|---|
Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; DNA, Neoplasm; Glaucarubin; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasm Proteins; Phenanthrenes; Quassins; Sesquiterpenes; Sesquiterpenes, Guaiane; Thymidine | 1981 |
Antitumor agents. XXXIV: Mechanism of action of bruceoside A and brusatol on nucleic acid metabolism of P-388 lymphocytic leukemia cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cells, Cultured; DNA, Neoplasm; Glaucarubin; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Pyrans; Quassins; RNA, Neoplasm | 1979 |